13 Percent of Patients With Anti-NMDA Receptor Encephalitis Have Suicidal Ideation

A recent study conducted by researchers at the University of California, San Francisco (UCSF) has revealed that 13 percent of patients with anti-NMDA receptor encephalitis, a rare neurological disorder, have suicidal ideation.

What is Anti-NMDA Receptor Encephalitis?

Anti-NMDA receptor encephalitis is a rare autoimmune disorder that affects the brain. It is caused by antibodies that attack the NMDA receptors in the brain, which are responsible for regulating communication between neurons. Symptoms of the disorder include seizures, confusion, hallucinations, memory loss, and difficulty speaking.

Suicidal Ideation in Patients With Anti-NMDA Receptor Encephalitis

In the study, researchers surveyed a total of 809 patients with anti-NMDA receptor encephalitis. Of those surveyed, 13 percent reported having suicidal ideation. The researchers also found that patients with more severe symptoms of the disorder were more likely to report suicidal ideation.

Implications of the Study

The findings of this study suggest that patients with anti-NMDA receptor encephalitis are at an increased risk for suicidal ideation. As such, it is important for healthcare providers to be aware of this risk and to provide appropriate support and treatment for these patients.

Summary:
This study revealed that 13 percent of patients with anti-NMDA receptor encephalitis have suicidal ideation. The findings suggest that these patients are at an increased risk for suicidal ideation and that healthcare providers should be aware of this risk and provide appropriate support and treatment. #AntiNMDA #SuicidalIdeation #NeurologicalDisorder #AutoimmuneDisorder #UCSF